(Combating New Crown Pneumonia) Zhong Nanshan: Two Antibody Kits Approved to Help Identify Influenza and New Crown Pneumonia Virus
China News Service, Guangzhou, February 23 (Cai Minjie) Zhong Nanshan, an academician of the Chinese Academy of Engineering, met with a Guangdong counterpart who supported the Jingzhou medical team in Hubei to conduct a remote consultation at the First Affiliated Hospital of Guangzhou Medical University on the 23rd. Zhong Nanshan said that from the current data, the Jingzhou epidemic situation has begun to take a turn for the better, and Jingzhou should focus on the treatment of critically ill patients to improve the cure rate.
At the meeting, Zhong Nanshan said that there were 630 new cases in Hubei Province on the 22nd, and the absolute number of new cases fell.
According to data from the Hubei Provincial Health and Health Committee, from 2:00 to 24:00 on February 22, there were 630 newly confirmed cases of new coronary pneumonia in the province, of which 8 were in Jingzhou.
In addition, Zhong Nanshan said that China's State Drug Administration has approved several drugs, one of which is a reagent on how to identify influenza, new crown pneumonia and parainfluenza, "this is a very important task."
In addition, two more qualified antibody kits were approved. "One of them is from Wanfu Biological in Guangdong. Both of these kits use colloidal gold method, which can detect the lgM antibody in patients. The lgM antibody can be detected on the 7th day or the third day of the onset, which is very helpful for the further diagnosis of the patient. "Zhong Nanshan said.
On the 22nd, China's State Drug Administration approved three new coronavirus detection products from three companies, including two colloidal gold antibody detection reagents and one thermostatic amplification chip nucleic acid detection reagent. Detection methods and means.
Zhong Nanshan said that the key to prevention and control at present is to separate patients with new coronary pneumonia from influenza patients. "China is currently in the season of high influenza. It is urgent to distinguish the two types of patients through rapid detection."
In addition, according to the introduction of Guangzhou Wanfu Biotechnology Co., Ltd., the company's approved new coronavirus antibody detection kit (colloidal gold method) is the first batch of new on-site rapid detection reagents for new coronavirus antibodies officially approved for marketing. Detection of new coronavirus IgM / IgG antibodies in human serum, plasma, and whole blood samples is easy to operate, and the results can be visually interpreted in 15 minutes, which can provide a rapid detection method for patients with suspected new coronary pneumonia.
According to reports, antibodies to the new coronavirus include IgM and IgG. A positive IgM antibody indicates a recent infection, while a positive IgG antibody indicates a longer infection or a previous infection. (Finish)